1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. COLORECTAL CANCER SCREENING MARKET BY SCREENING TEST
5.1. Introduction
5.2. Flexible Sigmoidoscopy
5.3. Stool-based Tests
5.4. CT Colonography
5.5. Colonoscopy
5.6. Others
6. COLORECTAL CANCER SCREENING MARKET BY END-USER
6.1. Introduction
6.2. Independent Diagnostic Labs
6.3. Hospitals
6.4. Others
7. COLORECTAL CANCER SCREENING MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Eiken Chemical Co. Ltd
9.2. Epigenomics Inc.
9.3. Exact Sciences Corporation
9.4. Polymedco Inc
9.5. Hemosure Inc.
9.6. F. Hoffmann-La Roche AG
9.7. QuidelOrtho Corporation
9.8. Siemens Healthineers AG
9.9. Sysmex Corporation
9.10. Olympus Corporation
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES